Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancer
Autor: | Céline Chapelle, Jane-Chloé Trone, Edouard Ollier, Nicolas Magné, Michel Cucherat, Paul Jacques Zuffrey, Patrick Mismetti, Silvy Laporte |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
Oncology medicine.medical_specialty Hypofractionated Radiation Therapy Active Comparator lcsh:Medicine Breast Neoplasms Article 03 medical and health sciences Prostate cancer 0302 clinical medicine Breast cancer Whole Breast Irradiation Prostate Internal medicine medicine Humans 030212 general & internal medicine lcsh:Science Randomized Controlled Trials as Topic Cancer Multidisciplinary business.industry lcsh:R Prostatic Neoplasms Partial Breast Irradiation medicine.disease Confidence interval medicine.anatomical_structure 030220 oncology & carcinogenesis Female Radiation Dose Hypofractionation lcsh:Q Neoplasm Recurrence Local business |
Zdroj: | Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020) Scientific Reports |
ISSN: | 2045-2322 |
Popis: | The aim of this study was to propose a methodology for the assessment of non-inferiority with meta-analysis. Assessment of hypofractionated RT in prostate and breast cancers is used as an illustrative example. Non-inferiority assessment of an experimental treatment versus an active comparator should rely on two elements: (1) an estimation of experimental treatment’s effect versus the active comparator based on a meta-analysis of randomized controlled trials and (2) the value of an objective non-inferiority margin. This margin can be defined using the reported effect of active comparator and the percentage of the active comparator’s effect that is desired to be preserved. Non-inferiority can then be assessed by comparing the upper bound of the 95% confidence interval of experimental treatment’s effect to the value of the objective non-inferiority margin. Application to hypofractionated RT in breast cancer showed that hypofractionated whole breast irradiation (HWBI) appeared to be non-inferior to conventionally fractionated RT for local recurrence. This was not the case for accelerated partial breast irradiation (APBI). Concerning overall survival, non-inferiority could not be claimed for either HWBI or APBI. For prostate cancer, the lack of demonstrated significant superiority of conventional RT versus no RT precluded any conclusion regarding non-inferiority of hypofractionated RT. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |